Relmada Therapeutics Inc. (RLMD)
NASDAQ: RLMD
· Real-Time Price · USD
0.60
-0.02 (-2.61%)
At close: Jul 02, 2025, 3:59 PM
0.61
1.19%
After-hours: Jul 02, 2025, 04:47 PM EDT
Relmada Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for RLMD stock have an median target of 1, with a low estimate of 1 and a high estimate of 13. The median target predicts an increase of 66.67% from the current stock price of 0.60.
Latest Analyst Insight Report
According to 3 stock analyst, the rating for Relmada Therapeutics Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.
Financial Forecast this Year
Revenue This Year
2.46M
from 0
Increased by -%
Revenue Next Year
10M
from 2.46M
Increased by 306.7%
EPS This Year
-1.93
from -2.65
Increased by 27.2%
EPS Next Year
-0.99
from -1.93
Increased by 48.7%